Prostate Cancer - Results from #22300

Robot assisted radical prostatectomy: How I do it. Part I: Patient preparation and positioning - Abstract November 12, 2013

Cigarette smoking is associated with an increased risk of biochemical disease recurrence, metastasis, castration-resistant prostate cancer, and mortality after radical prostatectomy: Results from the SEARCH database - Abstract November 12, 2013

Positive surgical margins: Rate, contributing factors and impact on further treatment: Findings from the Prostate Cancer Registry - Abstract November 12, 2013

Treating 'healthy' men who have localised cancer of the prostate - Abstract November 12, 2013

Differential tumor expression of inhibitor of differentiation-1 in prostate cancer patients with extreme clinical phenotypes and prognostic implications - Abstract November 12, 2013

Clinical significance of proliferative inflammatory atrophy in prostate biopsy - Abstract November 12, 2013

Characteristics of modern Gleason 9/10 prostate adenocarcinoma: A single tertiary centre experience within the Republic of Ireland - Abstract November 12, 2013

Impact of the type of ultrasound probe on prostate cancer detection rate and characterization in patients undergoing MRI-targeted prostate biopsies using cognitive fusion - Abstract November 12, 2013

Enzalutamide: A review of its use in metastatic, castration-resistant prostate cancer - Abstract November 12, 2013

The pre-treatment prevalence and types of sexual dysfunction among patients diagnosed with prostate cancer - Abstract November 12, 2013

Do theoretical potential and advanced technology justify the use of high-dose rate brachytherapy as monotherapy for prostate cancer? - Abstract November 11, 2013

Partnership status affects the association between gastrointestinal symptoms and quality of life after radiation therapy for prostate cancer - Abstract November 11, 2013

Dosimetric impact of Acuros XB dose calculation algorithm in prostate cancer treatment using RapidArc - Abstract November 11, 2013

Mayo study customizing treatments for deadly prostate cancer with tumor genomics November 11, 2013

Whole prostate D(90) and V(100): A dose-response analysis of 2000 consecutive 125I monotherapy patients - Abstract November 11, 2013

The validity and utility of the MD Anderson Symptom Inventory in patients with prostate cancer: Evidence from the Symptom Outcomes and Practice Patterns (SOAPP) data from the Eastern Cooperative Oncology Group - Abstract November 11, 2013

Translating clinical trials to clinical practice: Outcomes of men with metastatic castration resistant prostate cancer treated with docetaxel and prednisone in and out of clinical trials - Abstract November 11, 2013

Strontium-89 for prostate cancer with bone metastases: The potential of cancer control and improvement of overall survival - Abstract November 11, 2013

Predicting utility scores for prostate cancer: Mapping the Prostate Cancer Index to the Patient-Oriented Prostate Utility Scale (PORPUS) - Abstract November 11, 2013

Performance of multiparametric MRI in men at risk of prostate cancer before the first biopsy: A paired validating cohort study using template prostate mapping biopsies as the reference standard - Abstract November 11, 2013

Page 1116 of 1458